Alginic Acid Coating for Controlled Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current controlled release systems for oral administration of medications face challenges in achieving extended therapeutic effects due to limited absorption windows in the upper gastrointestinal tract, and existing polymers like methyl- and ethyl cellulose are not considered natural or sustainable.
Innovation Solution
Aqueous dispersions of alginic acid with a plasticizer are used to form firm, flexible films that provide controlled drug permeation, offering a natural and sustainable alternative for extended release formulations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional polymers like methyl cellulose and ethyl cellulose are used for controlled release coatings, then controlled release function is achieved, but the materials are not considered natural or sustainable
Solution Approach 1:
The patent changes the material composition parameter from conventional synthetic polymers (methyl cellulose, ethyl cellulose, polyacrylates) to natural alginic acid derived from brown seaweeds. This parameter change maintains the controlled release function while eliminating the harmful factor of non-natural material composition, aligning with clean-label and sustainable sourcing requirements
Solution Approach 2:
The patent creates a composite coating system by combining alginic acid with specific plasticizers (such as glycerol, sorbitol, or their esters) to achieve the desired film properties. This composite approach allows the natural alginic acid to provide controlled release functionality while the plasticizer components enhance film flexibility and forming characteristics
2Ease of operation
If film thickness is reduced to improve dosage form appearance and patient compliance, then aesthetic appeal and compliance improve, but controlled release performance may be compromised
Solution Approach 1:
The patent changes the physical-chemical parameters of alginic acid through controlled dispersion techniques and plasticizer addition, enabling the formation of uniform, defect-free films at reduced thicknesses (50-150 μm) that maintain controlled release performance. The plasticizer modifies the polymer chain mobility and film morphology, allowing thinner films to achieve the same release characteristics as thicker conventional films
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The alginic acid films demonstrate controlled release of drugs over time, achieving zero-order kinetics and extended release profiles, even with low film thickness, enhancing bioavailability and therapeutic efficacy.
Implementation Method 1
these films from aqueous dispersions of alginic acid showed controlled drug permeation over time
Data Source
AI summary
The present invention relates to water-insoluble micro-dispersions comprising alginic acid, and in particular to water-insoluble micro-dispersions for the preparation of capsules and capsule films intended for controlled- or sustained release oral administration of medications, nutritional components and supplements.